biote Corp.
biote Corp. (BTMD) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · BTMD · as of Jun 8, 2026
Key Statistics
Explore biote Corp. Data
btmd stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 7 · Buy rate: 85.7%
The BTMD analyst consensus is Buy, based on ratings from 7 Wall Street analysts over the past 3 months. The average 12-month price target is $3.25, representing +38.89% upside from the current price of $2.34.
Competitors & Peers
btmd competitorsBTMD
ABOS
ACTU
ANIK
INO
JYNTStock Performance
Full HistoryAbout biote Corp.
biote Corp. is dedicated to supporting and developing medical practices that focus on hormone optimization. The company provides a comprehensive system for its Biote-certified healthcare professionals…
what is biote corp. · btmd stock overview · biote corp. company profile · who is biote corp. ceo · btmd NASDAQ · biote corp. headquarters · biote corp. business segments
About Stock Overview & Key Data
biote Corp. (BTMD) is a Healthcare company in the Medical - Care Facilities industry, listed on NASDAQ since Apr 28, 2021. As of the latest trading session, BTMD stock price is $2.34, with a market capitalization of $103.2M. The stock has returned -40.46% over the past 12 months and -10.00% year-to-date.
According to 7 Wall Street analysts, the consensus rating for biote Corp. stock is Buy, with an average 12-month price target of $3.25. In fiscal year 2025, biote Corp. reported revenue of $192.2M and net income of $27.0M. For detailed data — including biote Corp. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, biote Corp. (BTMD) stock price is $2.34. The stock is traded on NASDAQ under the ticker symbol BTMD. The 52-week range is $1.27 – $4.75.